Pharmacy Usual Items - BRICS

  • BRICS
  • Revenue in the Pharmacy Usual Items market is projected to reach US$73.50bn in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 4.87%, resulting in a market volume of US$93.21bn by 2029.
  • In global comparison, most revenue will be generated in China (US$48,050.00m in 2024).
  • In relation to total population figures, per person revenues of US$22.29 are generated in 2024.

Key regions: Japan, France, China, Australia, Europe

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Pharmacy Usual Items market in BRICS is experiencing significant growth and development due to various factors. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors all contribute to the expansion of this market. Customer preferences play a crucial role in driving the growth of the Pharmacy Usual Items market in BRICS. Consumers in these countries have a growing awareness of health and wellness, leading to an increased demand for over-the-counter medications and personal care products. Additionally, the aging population in BRICS countries has created a larger consumer base for pharmacy products, as older individuals often require regular medication and health-related items. Trends in the market further support the growth of the Pharmacy Usual Items market in BRICS. One notable trend is the increasing popularity of e-commerce platforms for purchasing pharmacy products. Online pharmacies provide convenience and accessibility to customers, allowing them to easily browse and purchase a wide range of products. This trend is particularly prevalent in urban areas, where consumers have access to the internet and prefer the convenience of online shopping. Local special circumstances also contribute to the development of the Pharmacy Usual Items market in BRICS. Each country in the BRICS group has its own unique healthcare system and regulations, which can impact the availability and accessibility of pharmacy products. For example, in some BRICS countries, pharmacies are the primary point of access for healthcare services, making them essential for the local population. Additionally, government initiatives and policies aimed at improving healthcare infrastructure and increasing access to medication can also drive the growth of the Pharmacy Usual Items market. Underlying macroeconomic factors also play a significant role in the development of the Pharmacy Usual Items market in BRICS. Economic growth and rising disposable incomes in these countries have led to an increase in consumer spending on healthcare products. As the middle class expands in BRICS countries, more individuals have the financial means to purchase pharmacy products, further driving market growth. Additionally, favorable government policies and investments in healthcare infrastructure contribute to the overall growth and development of the Pharmacy Usual Items market. In conclusion, the Pharmacy Usual Items market in BRICS is experiencing growth and development due to customer preferences, market trends, local special circumstances, and underlying macroeconomic factors. The increasing demand for over-the-counter medications and personal care products, along with the rise of e-commerce platforms, are driving market growth. Local healthcare systems and government initiatives also play a role in shaping the market, while economic growth and rising disposable incomes contribute to increased consumer spending on pharmacy products.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)